Renalytix plc Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities
Renalytix plc (RENXF) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities of 0 shares for the 12-month period ending 2023-06-30, per its 10-K filed 2023-09-28.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities · last filed 2023-09-28
- Renalytix plc incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
- Renalytix plc incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2022 was 976.05K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 12 month |
|---|---|
| 2023-06-30 | 0.00 shares 10-K · filed 2023-09-28 |
| 2022-06-30 | 976.05K shares 10-K · filed 2023-09-28 |